Terms: = Lung cancer AND NFKB2, ENSG00000077150, LYT10, LYT-10, 4791
13 results:
1. Construction and validation of an aging-related gene signature for prognosis prediction of patients with breast cancer.
Li J; Qi C; Li Q; Liu F
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1741. PubMed ID: 36323529
[TBL] [Abstract] [Full Text] [Related]
2. Polymorphisms of NF-κB pathway genes influence adverse drug reactions of gefitinib in NSCLC patients.
Xin S; Zhao Y; Wang C; Huang Y; Zhuang W; Ma Y; Huang M; Xu X; Wang X; Zhang L
Pharmacogenomics J; 2020 Apr; 20(2):285-293. PubMed ID: 31664190
[TBL] [Abstract] [Full Text] [Related]
3.
Chaszczewska-Markowska M; Kosacka M; Chryplewicz A; Dyła T; Brzecka A; Bogunia-Kubik K
Anticancer Res; 2019 Jun; 39(6):3269-3272. PubMed ID: 31177178
[TBL] [Abstract] [Full Text] [Related]
4. NF-kB2 Genetic Variations are Significantly Associated with Non-Small Cell lung cancer Risk and Overall Survival.
Dimitrakopoulos FD; Antonacopoulou AG; Kottorou AE; Maroussi S; Panagopoulos N; Koukourikou I; Scopa C; Kalofonou M; Koutras A; Makatsoris T; Papadaki H; Dougenis D; Brock M; Kalofonos HP
Sci Rep; 2018 Mar; 8(1):5259. PubMed ID: 29588475
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell lung cancer: A Network Meta-Analysis.
Yu SN; Liu GF; Li XF; Fu BH; Dong LX; Zhang SH
J Cell Biochem; 2017 Dec; 118(12):4782-4791. PubMed ID: 28520216
[TBL] [Abstract] [Full Text] [Related]
6. Inhibiting DX2-p14/ARF Interaction Exerts Antitumor Effects in lung cancer and Delays Tumor Progression.
Oh AY; Jung YS; Kim J; Lee JH; Cho JH; Chun HY; Park S; Park H; Lim S; Ha NC; Park JS; Park CS; Song GY; Park BJ
Cancer Res; 2016 Aug; 76(16):4791-804. PubMed ID: 27302160
[TBL] [Abstract] [Full Text] [Related]
7. The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100.
Zhang Z; Wang Y; Li C; Shi Z; Hao Q; Wang W; Song X; Zhao Y; Jiao S; Zhou Z
J Biol Chem; 2015 Aug; 290(32):19558-68. PubMed ID: 26112410
[TBL] [Abstract] [Full Text] [Related]
8. Cytokine gene variations associated with trait and state anxiety in oncology patients and their family caregivers.
Miaskowski C; Cataldo JK; Baggott CR; West C; Dunn LB; Dhruva A; Merriman JD; Langford DJ; Kober KM; Paul SM; Cooper BA; Aouizerat BE
Support Care Cancer; 2015 Apr; 23(4):953-65. PubMed ID: 25249351
[TBL] [Abstract] [Full Text] [Related]
9. Evidence of associations between cytokine gene polymorphisms and quality of life in patients with cancer and their family caregivers.
Alexander K; Cooper B; Paul SM; West C; Yates P; Kober KM; Aouizerat BE; Miaskowski C
Oncol Nurs Forum; 2014 Sep; 41(5):E267-81. PubMed ID: 25158664
[TBL] [Abstract] [Full Text] [Related]
10. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
[TBL] [Abstract] [Full Text] [Related]
11. Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D.).
Wang IC; Ustiyan V; Zhang Y; Cai Y; Kalin TV; Kalinichenko VV
Oncogene; 2014 Nov; 33(46):5391-6. PubMed ID: 24213573
[TBL] [Abstract] [Full Text] [Related]
12. Downregulation of Mig-6 in nonsmall-cell lung cancer is associated with EGFR signaling.
Li Z; Dong Q; Wang Y; Qu L; Qiu X; Wang E
Mol Carcinog; 2012 Jul; 51(7):522-34. PubMed ID: 21739478
[TBL] [Abstract] [Full Text] [Related]
13. Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes.
Matsubara D; Niki T; Ishikawa S; Goto A; Ohara E; Yokomizo T; Heizmann CW; Aburatani H; Moriyama S; Moriyama H; Nishimura Y; Funata N; Fukayama M
Cancer Sci; 2005 Dec; 96(12):844-57. PubMed ID: 16367903
[TBL] [Abstract] [Full Text] [Related]
